Magnesium is having a bit of a moment right now. Muscle recovery sprays formulated with magnesium claim to soothe ...

ORLANDO, Fla. (Ivanhoe Newswire) --- Heart disease is the leading cause of death in the U.S. Not getting enough exercise, ...

Vitamin B12 deficiency can affect people of any age, and symptoms can develop suddenly or slowly worsen over time. In the most severe cases, it even can mimic the effects of Alzheimer's disease ...

Initially disclosing a diagnosis of rheumatoid arthritis, he later revealed that he actually suffers from psoriatic arthritis - a chronic condition characterised by joint pain, swelling ...

Adam also apologised to his followers for having not been "very vocal" about his experience with arthritis lately. He told them in the recent post on Instagram: "[I'm] just struggling and trying ...

US-based pharmaceutical company Johnson & Johnson (J&J) has reported positive results from a Phase IIIb trial of its monoclonal antibody Tremfya (guselkumab) for active psoriatic arthritis (PsA).

For approximately 85% of patients diagnosed with psoriatic arthritis, the skin manifestations of psoriasis emerge first, with joint symptoms typically developing 7-10 years after initial skin ...

Patients with psoriatic arthritis (PsA) experienced longer diagnostic delays than matched patients with rheumatoid arthritis (RA). Patients with polyarticular PsA received less intensive disease ...

Since becoming a writer in 2019, Emily has developed significant experience covering viral pop culture moments and ... We offer the most up-to-date information from top experts, new research, and ...

Johnson & Johnson (NYSE:JNJ) on Friday announced topline results from Phase 3b APEX study of Tremfya (guselkumab) in patients with active psoriatic arthritis ... signs and symptoms and its ...

TREMFYA ® demonstrated clinically meaningful and statistically significant efficacy in patients with active psoriatic arthritis at risk for structural damage in Phase 3b study Topline results ...

TREMFYA ® demonstrated clinically meaningful and statistically significant efficacy in patients with active psoriatic arthritis at risk for structural damage in Phase 3b study Topline results ...